Cargando…
Anti-p-benzoquinone antibody level as a prospective biomarker to identify smokers at risk for COPD
BACKGROUND AND OBJECTIVE: Identification of smokers having predisposition to COPD is important for early intervention to reduce the huge global burden of the disease. Using a guinea pig model, we have shown that p-benzoquinone (p-BQ) derived from cigarette smoke (CS) in the lung is a causative facto...
Autores principales: | Banerjee, Santanu, Bhattacharyya, Parthasarathi, Mitra, Subhra, Kundu, Somenath, Panda, Samiran, Chatterjee, Indu B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485895/ https://www.ncbi.nlm.nih.gov/pubmed/28684907 http://dx.doi.org/10.2147/COPD.S134455 |
Ejemplares similares
-
Interaction of p-benzoquinone with hemoglobin in smoker’s blood causes alteration of structure and loss of oxygen binding capacity
por: Ghosh, Arunava, et al.
Publicado: (2016) -
Global metabolome profiling of exhaled breath condensates in male smokers with asthma COPD overlap and prediction of the disease
por: Ghosh, Nilanjana, et al.
Publicado: (2021) -
COPD and glycopyrronium responsiveness assessment: An appraisal
por: Bhattacharyya, Parthasarathi, et al.
Publicado: (2023) -
Authors’ reply
por: Kundu, Somenath, et al.
Publicado: (2011) -
Adult thoracic empyema: A comparative analysis of tuberculous and nontuberculous etiology in 75 patients
por: Kundu, Somenath, et al.
Publicado: (2010)